CliffBio
biologic

Natpara

parathyroid hormone

Loss of exclusivityJanuary 2027projected — 12-year biologic exclusivity estimate
CompanyTakeda Pharmaceuticals U.S.A., Inc.

Drug detail

Brand nameNatpara
Active ingredientparathyroid hormone
Strength50MCG
Dosage formFor Injection
RouteSubcutaneous
ModalityBiologic
FDA approvalJanuary 2015
Marketing statusRx

More from Takeda Pharmaceuticals U.S.A., Inc.

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Natpara patent cliff — loss of exclusivity January 2027 | CliffBio